Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DiscoveRx in Fremont, US, has purchased BioSeek, a provider of drug discovery services, for an undisclosed sum.
Subscribe to our email newsletter
Under the acquisition, DiscoveRx will add BioSeek’s BioMAP drug screening platform to its drug discovery solutions portfolio which includes GPCR, Kinase, and NHR assay solutions and KINOMEscan technology.
The BioMAP drug screening platform, which is based on cell-based disease models, generates predictive biological activity profiles for potential treatments.
DiscoveRx president and chief executive officer Pyare Khanna said the integration of BioSeek provides two new capabilities to the company.
"Expertise in primary cell disease models as well as a highly differentiated compound characterization service," Khanna added.
"These new capabilities further strengthen our position as a premier drug discovery solution provider that develops and commercializes high-value products and specialized services."